FR2166316B1 - - Google Patents

Info

Publication number
FR2166316B1
FR2166316B1 FR7200514A FR7200514A FR2166316B1 FR 2166316 B1 FR2166316 B1 FR 2166316B1 FR 7200514 A FR7200514 A FR 7200514A FR 7200514 A FR7200514 A FR 7200514A FR 2166316 B1 FR2166316 B1 FR 2166316B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7200514A
Other languages
French (fr)
Other versions
FR2166316A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to FR7200514A priority Critical patent/FR2166316A1/fr
Publication of FR2166316A1 publication Critical patent/FR2166316A1/fr
Application granted granted Critical
Publication of FR2166316B1 publication Critical patent/FR2166316B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D501/06—Acylation of 7-aminocephalosporanic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7200514A 1972-01-07 1972-01-07 7-acylcephalosporins - prepd via a silylated inter Granted FR2166316A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7200514A FR2166316A1 (en) 1972-01-07 1972-01-07 7-acylcephalosporins - prepd via a silylated inter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7200514A FR2166316A1 (en) 1972-01-07 1972-01-07 7-acylcephalosporins - prepd via a silylated inter

Publications (2)

Publication Number Publication Date
FR2166316A1 FR2166316A1 (en) 1973-08-17
FR2166316B1 true FR2166316B1 (enrdf_load_html_response) 1977-10-28

Family

ID=9091611

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7200514A Granted FR2166316A1 (en) 1972-01-07 1972-01-07 7-acylcephalosporins - prepd via a silylated inter

Country Status (1)

Country Link
FR (1) FR2166316A1 (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states

Also Published As

Publication number Publication date
FR2166316A1 (en) 1973-08-17

Similar Documents

Publication Publication Date Title
JPS5734255B2 (enrdf_load_html_response)
CH577888A5 (enrdf_load_html_response)
CH574217A5 (enrdf_load_html_response)
BG17850A1 (enrdf_load_html_response)
BG17876A1 (enrdf_load_html_response)
BG18263A1 (enrdf_load_html_response)
BG18391A1 (enrdf_load_html_response)
BG18489A1 (enrdf_load_html_response)
BG19416A1 (enrdf_load_html_response)
CH380973A4 (enrdf_load_html_response)
CH545667A (enrdf_load_html_response)
CH562667A5 (enrdf_load_html_response)
CH562927A5 (enrdf_load_html_response)
CH563700A5 (enrdf_load_html_response)
CH565091A5 (enrdf_load_html_response)
CH565663A5 (enrdf_load_html_response)
CH565696A5 (enrdf_load_html_response)
CH565732A5 (enrdf_load_html_response)
CH568368A5 (enrdf_load_html_response)
CH569946A5 (enrdf_load_html_response)
CH570298A5 (enrdf_load_html_response)
CH570569A5 (enrdf_load_html_response)
CH571664A5 (enrdf_load_html_response)
CH571907A5 (enrdf_load_html_response)
CH572024A5 (enrdf_load_html_response)

Legal Events

Date Code Title Description
ST Notification of lapse